PISAPIA, PASQUALE
 Distribuzione geografica
Continente #
AS - Asia 6.278
NA - Nord America 4.710
EU - Europa 3.888
SA - Sud America 696
AF - Africa 120
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.704
Nazione #
US - Stati Uniti d'America 4.507
SG - Singapore 2.861
RU - Federazione Russa 1.805
CN - Cina 1.127
VN - Vietnam 1.012
IT - Italia 977
HK - Hong Kong 570
BR - Brasile 556
DE - Germania 261
FR - Francia 209
IN - India 172
GB - Regno Unito 115
NL - Olanda 114
CA - Canada 102
JP - Giappone 97
KR - Corea 91
FI - Finlandia 88
ES - Italia 71
BD - Bangladesh 69
MX - Messico 65
AR - Argentina 57
UA - Ucraina 45
IQ - Iraq 39
PH - Filippine 35
PL - Polonia 34
ZA - Sudafrica 34
IE - Irlanda 32
EC - Ecuador 29
PK - Pakistan 26
AT - Austria 23
SE - Svezia 23
TH - Thailandia 23
TR - Turchia 20
CI - Costa d'Avorio 19
ID - Indonesia 18
TW - Taiwan 16
JO - Giordania 15
LT - Lituania 15
UZ - Uzbekistan 13
VE - Venezuela 12
EG - Egitto 11
MA - Marocco 10
RO - Romania 10
CL - Cile 9
JM - Giamaica 9
PE - Perù 9
BE - Belgio 8
CH - Svizzera 8
DZ - Algeria 8
KE - Kenya 8
NP - Nepal 8
RS - Serbia 8
TN - Tunisia 8
AU - Australia 7
CO - Colombia 7
MY - Malesia 7
PY - Paraguay 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
GR - Grecia 5
HU - Ungheria 5
OM - Oman 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
PT - Portogallo 4
UY - Uruguay 4
BS - Bahamas 3
CR - Costa Rica 3
GA - Gabon 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
SV - El Salvador 3
TZ - Tanzania 3
AD - Andorra 2
BN - Brunei Darussalam 2
EE - Estonia 2
ET - Etiopia 2
GD - Grenada 2
GF - Guiana Francese 2
IR - Iran 2
LY - Libia 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
Totale 15.673
Città #
Singapore 1.438
San Jose 946
Hong Kong 548
Moscow 448
Ashburn 436
Hefei 388
Chandler 381
Ho Chi Minh City 290
Beijing 272
Hanoi 232
Naples 208
Santa Clara 153
Lauterbourg 146
Los Angeles 140
The Dalles 140
Millbury 107
Munich 100
Lawrence 89
Tokyo 84
Milan 81
Des Moines 79
New York 75
Seoul 74
Redondo Beach 71
Kochi 63
Buffalo 62
Napoli 62
São Paulo 59
Dallas 54
Haiphong 51
Helsinki 51
Rome 49
Amsterdam 46
Boston 45
Frankfurt am Main 42
Wilmington 42
Valencia 40
Da Nang 39
Council Bluffs 38
Orem 37
Seattle 30
Chennai 28
Montreal 27
Atlanta 25
Falkenstein 24
Chicago 23
Mexico City 23
Rio de Janeiro 23
Biên Hòa 22
London 22
Nanjing 22
Warsaw 22
Ottawa 21
Brooklyn 20
Fairfield 20
Johannesburg 20
Baghdad 19
Dublin 19
Can Tho 18
Houston 18
Turku 17
Nuremberg 16
Phoenix 16
Stockholm 16
Toronto 16
Hải Dương 15
Amman 14
Denver 14
San Francisco 14
Belo Horizonte 12
Brasília 12
Lappeenranta 12
Princeton 12
Ankara 11
Düsseldorf 11
Ninh Bình 11
Redwood City 11
Bologna 10
Curitiba 10
Salerno 10
Tashkent 10
Turin 10
Kronberg 9
Quito 9
Bari 8
Florence 8
Guangzhou 8
Guayaquil 8
Karachi 8
Memphis 8
Messina 8
Pune 8
Roubaix 8
Salt Lake City 8
Shanghai 8
Vienna 8
Woodbridge 8
Bangkok 7
Buenos Aires 7
Falls Church 7
Totale 8.575
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 223
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 188
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 182
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 162
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 157
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 156
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 154
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 154
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 152
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 152
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 150
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 149
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 148
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 148
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 148
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 145
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 144
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 144
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 143
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 138
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 137
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 137
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 137
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 136
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 135
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 135
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 135
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 133
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 133
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 132
Next generation sequencing in cytology 131
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 130
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 130
Role of Cytomorphology in the Era of Liquid Biopsy 130
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 130
Predictive molecular pathology in the time of COVID-19 129
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 128
Methods for actionable gene fusion detection in lung cancer: now and in the future 128
The role of liquid biopsy in epithelial ovarian cancer: state of the art 127
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 127
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 125
The evolving role of liquid biopsy in lung cancer 124
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 124
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 123
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 123
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 121
Brca1/2 ngs somatic testing in clinical practice: a short report 121
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 120
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 120
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 119
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 119
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 119
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 119
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 118
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 118
Osimertinib 118
Tumor mutational burden on cytological samples: A pilot study 118
BRAF: A Two-Faced Janus 118
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 117
BRAF mutations in lung cancer 117
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 117
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 116
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 116
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 114
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 114
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 114
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 114
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 113
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 113
A narrative review of lung cancer cytology in the times of coronavirus: What physicians should know 112
Interobserver variability in cytopathology: How much do we agree? 111
How to prepare cytological samples for molecular testing 111
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 111
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 110
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 110
Invited review—next-generation sequencing: a modern tool in cytopathology 109
Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment 109
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 108
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 107
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 106
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 105
Liquid Biopsy and Lung Cancer 105
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 104
Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls 101
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 100
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 100
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 98
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 97
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 97
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 96
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer 96
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 96
Liquid biopsy testing in urological cancers: Focus on urine 94
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 93
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 90
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 90
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 88
Interventional cytopathologist perspective on the Milan System Classification: a study on 929 consecutive salivary gland fine-needle aspirations with a focus on challenging diagnostic categories 87
Juggling the COVID-19 pandemic: A cytopathology point of view 86
Critical aspects of MSI testing in endometrial cancer: a comparison study 84
Totale 12.320
Categoria #
all - tutte 49.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 0 21
2021/2022623 42 15 21 9 11 12 16 69 22 51 132 223
2022/2023923 116 58 40 67 125 115 4 107 172 44 58 17
2023/2024713 42 123 50 29 29 37 25 98 22 38 127 93
2024/20254.400 204 235 21 22 99 191 465 275 306 621 1.563 398
2025/20268.725 861 795 911 779 1.419 360 1.032 587 1.033 585 285 78
Totale 15.969